copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
BiliTool™ BiliTool provides care recommendations for newborn infants with jaundice (hyperbilirubinemia) at risk for bilirubin encephalopathy and kernicterus
(2022) Hyperbilirubinemia management guidelines - PediTools Pediatric clinical calculators and toolsUsage Notes Can leave bilirubin blank to view thresholds Enter a comma-separated list of ages and bilirubin levels to assess trends Management recommendations will be based on the latest age Neurotoxicity Risk Factors albumin < 3 g dL isoimmune hemolytic disease G6PD deficiency other hemolytic conditions sepsis clinical instability in previous 24 hours
Bilirubin: Bilitool Bili Tool on the App Store Offline Bilitool in one screen Based on the 2022 American Academy of Pediatrics (AAP) "Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation" guidelines
Neonatal Practice Tool: Hyperbilirubinemia Clinicians can evaluate a patient’s need for exchange transfusion using graphs in III F of the Clinical Practice Guidelines, or using Bilitool org
(2004) Hyperbilirubinemia management guidelines - PediTools Pediatric clinical calculators and toolsTips and Tricks Enter an age and bilirubin level Or, can enter a comma-separated list of ages and bilirubin levels, to assess trends on the plot Treatment recommendations will be based on the latest age Or, can enter just an age (with no bilirubin levels) to check what thresholds are at that age Based on Management of hyperbilirubinemia in the newborn
Hyperbilirubinemia Hyperbilirubinemia Overview Severe hyperbilirubinemia can cause kernicterus, a type of brain damage that leads to movement problems (cerebral palsy) and hearing loss Informed guidance on hyperbilirubinemia management, including preventive treatment thresholds, is critical to safely minimize neurodevelopmental risk AAP Recommendations In August 2022, the Academy released updated clinical